Breakthrough Science. Breakthrough Medicine. Trademark Details
Word Mark | Breakthrough Science. Breakthrough Medicine. |
---|---|
Status | Dead Registered 710 — Cancelled - Section 8 |
Current Owner
Millennium Pharmaceuticals, Inc. of Cambridge, MA
View all trademarks for Millennium Pharmaceuticals, Inc.Serial Number | 78171952 |
---|---|
Registration Number | 3030017 |
Status Date | Friday, July 20, 2012 |
Filing Date | Friday, July 20, 2012 |
Registration Date | Tuesday, December 13, 2005 |
Attorney | Michael J. Bevilacqua, Esquire |
Correspondent
Nancy C. DiConza
Fross Zelnick Lehrman and Zissu, P.C.
966 United Nations Plaza
New York NY 10017
Fross Zelnick Lehrman and Zissu, P.C.
966 United Nations Plaza
New York NY 10017
Case File Statements
Goods & Services | Research Services, Namely, Research, Development, Validation, Testing, Data Analysis and Product Development Services in the Biomedical, Genomic Pharmacogenomic, Diagnostic, Clinical Trial Design, and Biotechnology Fields; Research Consulting Services, Namely, Research, Development, Validation, Testing, Data Analysis, and Product Development Services for Others in the Biomedical, Genomic, Pharmaceutical, Pharmacogenomics, Diagnostic, Clinical Trial Design, and Biotechnology Fields; Consultation Services, Namely, Providing Consultation to Others via Global, National, and Local Computer Networks in the Fields of Life Sciences, Pharmacogenomics, Diagnostics, Clinical Trial Design and Biotechnology; Providing on-Line Computer Databases via Global, National, and Local in the Fields of Life Sciences, Pharmacogenomics, Diagnostics, Clinical Trial Design and Biotechnology |
---|---|
Goods & Services | Medical and Diagnostic Services, Namely, Diagnosing, Preventing, and Predicting Disease, Identifying Hereditary Risk Factors, Diagnostic Testing, Prognostic Testing, Gene and Protein Testing, Identifying Physiological Characteristics, Establishing Individual Preventative Programs, Establishing Disease Treatment Based on Gene and Protein Expression and/or Activity, Evaluating Clinical Trial Progress, Drug Monitoring and Computer Tracking of a Patient's Health Progress |
Classifications
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, July 20, 2012 |
First Use Anywhere | Tuesday, August 23, 2005 |
First Use In Commerce | Tuesday, August 23, 2005 |
Primary Code | 042 |
International Class Codes |
044
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Friday, July 20, 2012 |
First Use Anywhere | Tuesday, August 23, 2005 |
First Use In Commerce | Tuesday, August 23, 2005 |
Primary Code | 044 |
Trademark Timeline
-
Oct 07 2002Trademark application filed with USPTO
-
Mar 14 2003Assigned To Examiner
-
Mar 17 2003Non-Final Action Mailed
-
Sep 17 2003Correspondence Received In Law Office
-
Sep 22 2003Correspondence Received In Law Office
-
Sep 22 2003Paper Received
-
Oct 27 2003Case File In Ticrs
-
Nov 13 2003Approved For Pub - Principal Register
-
Dec 17 2003Notice of Publication
-
Jan 06 2004Published For Opposition
-
Jan 09 2004Extension of Time To Oppose Received
-
May 21 2004Teas Change of Correspondence Received
-
Aug 18 2004Extension of Time To Oppose Process - Terminated
-
Oct 19 2004Noa Mailed - Sou Required From Applicant
-
Apr 18 2005Extension 1 Filed
-
Apr 18 2005Paper Received
-
May 10 2005Extension 1 Granted
-
Aug 23 2005First use anywhere for the mark
-
Aug 23 2005First use in commerce for the mark
-
Aug 23 2005First use anywhere for the mark
-
Aug 23 2005First use in commerce for the mark
-
Sep 27 2005Use Amendment Filed
-
Sep 30 2005Paper Received
-
Oct 13 2005Statement of Use Processing Complete
-
Oct 17 2005Allowed Principal Register - Sou Accepted
-
Oct 21 2005Assigned To Lie
-
Oct 26 2005Law Office Registration Review Completed
-
Dec 13 2005Registered-Principal Register
-
Dec 13 2005Trademark officially registered with the USPTO
-
Jul 20 2012Cancelled Sec. 8 (6-Yr)